July 2026
The global oral solid dose oncology CDMO market is growing with rising demand for outsourced cancer drug manufacturing and advanced solid dosage formulation.
August 2026
The oncology CDMO market is expanding rapidly, fueled by rising cancer prevalence, growing demand for advanced therapies like ADCs and cell & gene therapies, and the increasing need for specialized outsourcing services.
February 2026
The global oral oncology specialty pharmacy market is driven by rising cancer burden, increasing use of oral anticancer drugs, and expansion of specialty pharmacy services worldwide.
September 2026
The global oral mucositis treatment market size is estimated to hit around USD 3.96 billion by 2035 increasing from USD 2.13 billion in 2026, with a CAGR of 7.12%.
September 2026
The global behavioral rehabilitation market size accounted for USD 284.95 billion in 2026 and is expected to hit USD 455.48 billion by 2035, at a CAGR of 5.35%.
September 2026
The oncology/cancer drugs market size is calculated at USD 214.70 billion in 2026 and is projected to hit around USD 554.69 billion by 2035 with a CAGR of 11.17%.
September 2026
The global cognitive behavioral therapy market size is expected to attain around USD 34.04 billion by 2034 from USD 10.48 billion in 2026 with a CAGR of 15.96%.
September 2026
The global live biotherapeutic products and microbiome CDMO market size is estimated to hit around USD 1,838.56 million by 2035 from USD 106.79 million in 2026, at a CAGR of 37.38%.
September 2026
The LNP CDMO market reached USD 271.03 million in 2026, featuring leading LNP CDMO market companies such as Lonza Group, WuXi AppTec, Samsung Biologics.
September 2026
The rare disease small-batch CDMO market is expanding with demand for specialized manufacturing of orphan drugs and niche therapies.
September 2026
The global oral care products dental consumables market size is estimated to hit around USD 66.46 billion by 2035 increasing from USD 70.55 billion in 2026, with a CAGR of 6.14%.
September 2026
The global solid state LiDaR market size was evaluated at USD 2.64 billion in 2026 and is predicted to hit around USD 13.79 billion by 2035, growing at a CAGR of 20.15%.
September 2026
The U.S. behavioral health market is projected to grow from USD 100.9 billion in 2026 to USD 174.78 billion by 2035, registering a CAGR of 6.31%.
September 2026
The global solid state drive market size accounted for USD 66.32 billion in 2026 and is predicted to hit around USD 304.73 billion by 2035, at a CAGR of 18.52%.
September 2026
The solid waste management market size is projected to hit around USD 459.32 billion by 2035 from USD 318.03 billion in 2026 with a CAGR of 4.17%.
September 2026
Europe Pharmaceutical CDMO market size is projected to hit around USD 94.94 billion by 2035, rising from USD 49.06 billion in 2026, growing at a CAGR of 7.59%.
September 2026
The oral transmucosal drugs market size was valued at USD 41.82 billion in 2026 and is projected to attain around USD 70.37 billion by 2034 with a CAGR of 6.72%.
September 2026
The global oral obesity therapies market size was evaluated at USD 4.70 billion in 2026 and is predicted to hit around USD 9.34 billion by 2035, growing at a CAGR of 7.94%.
September 2026
The global behavioral health market size was calculated at USD 197.34 billion in 2026 and is expected to hit around USD 349.88 billion by 2035 with a notable CAGR of 6.58%.
September 2026
The global oncology molecular diagnostic market size was valued at USD 3.42 billion in 2026 and is expected to surge around USD 8.50 billion by 2034, at a CAGR of 11.99%.
September 2026
The global oncology clinical trials market size is expected to worth around USD 22.76 billion by 2034 from USD 13.60 billion in 2024 with a CAGR of 5.28%.
September 2026
The global biologics CDMO market size was valued at USD 25.08 billion in 2026 and is projected to hit around USD 55.11 billion by 2035 with a healthy CAGR of 9.14%.
September 2026
The chemical drug CDMO market size was USD 14.32 billion in 2026, with leading chemical drug CDMO market players including Almac Group, BASF SE, Boehringer Ingelheim, Cipla Limited.
September 2026
The chemical API CDMO market size was USD 18.36 billion in 2026, with leading chemical API CDMO market players including Lonza Group, WuXi AppTec, Samsung Biologics, Boehringer Ingelheim.
September 2026
The solid-state transformers market reached USD 35.05 billion in 2026, featuring leading solid-state transformers market companies such as ABB Ltd., Eaton Corporation.
September 2026
The immuno-oncology antibodies market established a strong position in 2026 and is projected to expand significantly from 2026 through 2035, driven by increasing demand, evolving market needs, technological advancements, and growing adoption across key industries.
September 2026
The global behavioral and mental health software market size was estimated at USD 8.79 billion in 2026 and is predicted to reach around USD 30.62 billion by 2034, at a CAGR of 16.98%.
August 2026
The hormonal drug CDMO market is expanding with rising demand for outsourced development and manufacturing of therapies for endocrine and reproductive health.
August 2026
The high-potency API (HPAPI) CDMO market is expanding with rising demand for oncology drugs, targeted therapies, and advanced containment solutions.
August 2026
The global precision oncology market size is calculated at USD 133 billion in 2025 and is projected to hit around USD 338.89 billion by 2035 with a CAGR of 11.33%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com